Mesoblast Ltd expected to post a loss of 13 cents a share - Earnings Preview

Mesoblast

29/08/2023 12:01

* Mesoblast Ltd  MSB.AX   is expected to show a rise in
quarterly
revenue when it reports  results 
    * The Melbourne Victoria-based  company is expected to
report  a
49.4% increase in revenue to $3.325 million from $2.23 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Mesoblast Ltd is
for a
loss of 13 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Mesoblast
Ltd is
A$0.91​, above​ its last closing price of A$0.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023              -0.05      -0.02     Beat    50
 Dec. 31 2023              -0.06      -0.03     Beat    47.6
 Sep. 30 2022  -0.05       -0.05      -0.02     Beat    52​
 Jun. 30 2022              -0.05      -0.03     Beat    34
 ​​Mar.        -0.04       -0.04      -0.03     Beat    17.5
 31 2022                                                
 Dec. 31 2021              -0.05      -0.04     Beat    20​
 Sep. 30 2021  -0.03       -0.03      -0.03     Met     -16.7
 This summary was machine generated August 29 at 11:01 GMT.  All
figures in US dollars  unless otherwise stated